Cargando…

When Can We Lift Non‐Pharmaceutical Interventions with the Availability of COVID‐19 Vaccine in the United States?

RESEARCH OBJECTIVE: Coronavirus disease 2019 (COVID‐19), a global pandemic, has disproportionately inflicted deaths and affected the US economy. With the recent emergency use authorization of COVID‐19 vaccines, ongoing non‐pharmaceutical interventions (NPIs) could be lifted in the future. Our object...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chhatwal, Jagpreet, Dalgic, Ozden O., Mesa‐Frias, Marco, Buyukkaramikli, Nasuh, Cox, Andrew, Van Effleterre, Thierry, Griffin, Adrian, Ayer, Turgay, Yildirim, Ismail F., Patterson, Brandon J., El Khoury, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2021
Materias:	Special Issue Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441278/ http://dx.doi.org/10.1111/1475-6773.13832

Ejemplares similares

Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions
por: Linas, Benjamin P., et al.
Publicado: (2022)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
por: Aggarwal, Rakesh, et al.
Publicado: (2017)

Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases
por: Toumi, Asmae, et al.
Publicado: (2021)

Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
por: Chen, Qiushi, et al.
Publicado: (2020)

Economic Burden of COVID-19: A Systematic Review
por: Richards, Fayolah, et al.
Publicado: (2022)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
por: Chen, Qiushi, et al.
Publicado: (2019)

Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
por: Odhiambo, Raymond, et al.
Publicado: (2013)

PIN68 COVID-19 Simulator: An Interactive Tool to Inform COVID-19 Intervention Policy Decisions in the United States
por: Chhatwal, J., et al.
Publicado: (2020)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

What Is the Optimal Threshold at Which to Recommend Breast Biopsy?
por: Burnside, Elizabeth S., et al.
Publicado: (2012)

Value of information analysis in telehealth for chronic heart failure management
por: Grustam, Andrija S., et al.
Publicado: (2019)

TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility
por: Büyükkaramikli, Nasuh C., et al.
Publicado: (2019)

Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium
por: Postma, Maarten J., et al.
Publicado: (2023)

Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”
por: Postma, Maarten J., et al.
Publicado: (2023)

Alcohol-Associated Liver Disease Mortality Rates by Race Before and During the COVID-19 Pandemic in the US
por: Kulkarni, Neeti S., et al.
Publicado: (2023)

Total Facelift: Forehead Lift, Midface Lift, and Neck Lift
por: Park, Dong Man
Publicado: (2015)

Severity-Adjusted Probability of Being Cost Effective
por: Versteegh, Matthijs M., et al.
Publicado: (2019)

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
por: Ferrante, Shannon Allen, et al.
Publicado: (2013)

A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States
por: Chiosi, John J., et al.
Publicado: (2023)

Lift
por: Quinn, Ryan
Publicado: (2015)

Subcutaneous lateral brow lift (“Z-lift”)
por: Ueberreiter, Klaus, et al.
Publicado: (2015)

Grappling with COVID-19 by imposing and lifting non-pharmaceutical interventions in Sri Lanka: A modeling perspective
por: Jayaweera, Mahesh, et al.
Publicado: (2021)

The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review
por: Cacciatore, Pasquale, et al.
Publicado: (2020)

Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
por: Zhuo, Yueran, et al.
Publicado: (2020)

Reduction of COVID-19 Incidence and Nonpharmacologic Interventions: Analysis Using a US County–Level Policy Data Set
por: Ebrahim, Senan, et al.
Publicado: (2020)

Artificial Neural Networks in Mammography Interpretation and Diagnostic Decision Making
por: Ayer, Turgay, et al.
Publicado: (2013)

Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Büyükkaramikli, Nasuh C., et al.
Publicado: (2018)

Lifting speed preferences and their effects on the maximal lifting capacity
por: LIN, Chiuhsiang Joe, et al.
Publicado: (2016)

Asian Face Lift with the Composite Face Lift Technique
por: Wong, Chin-Ho, et al.
Publicado: (2021)

Why should we apply ABM for decision analysis for infectious diseases?—An example for dengue interventions
por: Miksch, Florian, et al.
Publicado: (2019)

Normalized Lift: An Energy Interpretation of the Lift Coefficient Simplifies Comparisons of the Lifting Ability of Rotating and Flapping Surfaces
por: Burgers, Phillip, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kb8ee2l6mclno3r743l0mb86kn